Literature DB >> 7773598

Postoperative wound infection rates in dermatologic surgery.

T Futoryan1, D Grande.   

Abstract

BACKGROUND: Multiple factors related to the nature of the surgical procedure can influence the risk of wound infection in dermatologic surgery. Despite that, wound infection rates in dermatologic surgical procedures are believed to be low.
OBJECTIVE: This study was conducted: 1) to determine wound infection rates in Mohs and excisional surgery; and 2) to investigate if factors such as lesion type, anatomic location, postoperative defect size, number of Mohs stages required to achieve a tumor-free plane, and the type of reconstructive procedure influence the rate of surgical wound infections.
RESULTS: Wound infection rate for 530 Mohs procedures and 517 excisions combined was 2.29%, falling within the predicted range for "clean" surgical procedures. In addition, Mohs procedures performed on the ear as well as large postoperative defects were found to have a higher rate of wound infections.
CONCLUSION: Dermatologic surgery can be safely performed in an outpatient setting without a significant risk of infection. Certain anatomic sites, such as the ear, as well as size of postoperative defect, are important factors in predicting the risk of postoperative wound infection.

Entities:  

Mesh:

Year:  1995        PMID: 7773598     DOI: 10.1111/j.1524-4725.1995.tb00255.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  14 in total

1.  Video education provides effective wound care instruction pre- or post-mohs micrographic surgery.

Authors:  Monica M Van Acker; Mark A Kuriata
Journal:  J Clin Aesthet Dermatol       Date:  2014-04

Review 2.  [Perioperative antibiotic prophylaxis in dermatosurgery-2019 status quo].

Authors:  J Lammer; A Böhner; T Volz
Journal:  Hautarzt       Date:  2019-11       Impact factor: 0.751

3.  [Single center analysis of the dermatosurgical patient cohort of a tumor center in Germany].

Authors:  A Lobeck; C Weiss; A Orouji; P-S Koch; M Heck; J Utikal; W Koenen; J Faulhaber; C-D Klemke; M Felcht
Journal:  Hautarzt       Date:  2017-05       Impact factor: 0.751

Review 4.  [Ambulatory dermatologic surgery].

Authors:  T Dirschka; N von Schroeders; M Heiss; W Büchel
Journal:  Hautarzt       Date:  2005-05       Impact factor: 0.751

5.  Use of Antibiotics for Dermatologic Procedures From 2008 to 2016.

Authors:  John S Barbieri; Jeremy R Etzkorn; David J Margolis
Journal:  JAMA Dermatol       Date:  2019-04-01       Impact factor: 10.282

6.  Alcoholic versus aqueous chlorhexidine for skin antisepsis: the AVALANCHE trial.

Authors:  Daniel Charles; Clare F Heal; Meth Delpachitra; Michael Wohlfahrt; Debbie Kimber; Julie Sullivan; Sheldon Browning; Sabine Saednia; Alexandra Hardy; Jennifer Banks; Petra Buttner
Journal:  CMAJ       Date:  2017-08-08       Impact factor: 8.262

7.  Retrospective Clinical Trial of Fusidic Acid versus Petrolatum in the Postprocedure Care of Clean Dermatologic Procedures.

Authors:  Dong Hun Lee; Dong Young Kim; So Young Yoon; Hyun Sun Park; Hyun-Sun Yoon; Soyun Cho
Journal:  Ann Dermatol       Date:  2015-02-03       Impact factor: 1.444

8.  Trends in Oral Antibiotic Prescription in Dermatology, 2008 to 2016.

Authors:  John S Barbieri; Ketaki Bhate; Kathleen P Hartnett; Katherine E Fleming-Dutra; David J Margolis
Journal:  JAMA Dermatol       Date:  2019-03-01       Impact factor: 10.282

9.  The characteristics of Mohs surgery performed by dermatologists who learned the procedure during residency training or through postgraduate courses and observational preceptorships.

Authors:  Howard K Steinman; Henry Clever; Anthony Dixon
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-04

10.  Prevention of surgical site infection in lower limb skin lesion excisions with single dose oral antibiotic prophylaxis: a prospective randomised placebo-controlled double-blind trial.

Authors:  Samuel C Smith; Clare F Heal; Petra G Buttner
Journal:  BMJ Open       Date:  2014-07-30       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.